Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Reflects CMS Open Payments as of 2026-07-26T04:22:22Z. CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Covered recipient · General Payments record

DAVID B PAGE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1922241140
CMS profile
475427
Location
PORTLAND, OR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

General Payments · PY2019–2025

  • CMS publication 2026-06-30

Latest program year · PY2025

$39,201.80

51 records · 0 disputed

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $30,270.00 10
Travel and Lodging $6,908.80 15
Long term medical supply or device loan $1,098.18 12
Food and Beverage $919.49 13
Education $5.33 1

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $11,726.72 19
Merck Sharp & Dohme Corporation $9,522.40 10
Stemline Therapeutics Inc. $7,476.51 7
Eli Lilly and Company $4,400.00 2
PFIZER INC. $3,077.37 4
Acerta Pharma LLC $1,655.20 4
Daiichi Sankyo Inc. $1,138.60 3
Caris MPI, Inc. $162.40 1
Gilead Sciences, Inc. $42.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $45,283.96 51
PY2020 $8,353.58 8
PY2021 $52,310.88 40
PY2022 $47,622.22 51
PY2023 $19,147.23 28
PY2024 $25,944.90 46
PY2025 $39,201.80 51

Payment records · PY2025 (51)

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novartis Pharmaceuticals Corporation $83.33 12/30/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720203 CMS
Stemline Therapeutics Inc. $5.33 12/19/2025 Education No dispute reported 06/30/2026 1244091696 CMS
Daiichi Sankyo Inc. $277.50 12/17/2025 Consulting Fee No dispute reported 06/30/2026 1197097071 CMS
AstraZeneca Pharmaceuticals LP $125.00 12/11/2025 Food and Beverage No dispute reported 06/30/2026 1206856298 CMS
Daiichi Sankyo Inc. $28.60 12/03/2025 Food and Beverage No dispute reported 06/30/2026 1197097639 CMS
Novartis Pharmaceuticals Corporation $83.33 11/26/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720191 CMS
Caris MPI, Inc. $162.40 11/20/2025 Food and Beverage No dispute reported 06/30/2026 1234283992 CMS
PFIZER INC. $1,257.62 11/02/2025 Travel and Lodging No dispute reported 06/30/2026 1230236736 CMS
PFIZER INC. $442.26 11/02/2025 Travel and Lodging No dispute reported 06/30/2026 1230237301 CMS
Novartis Pharmaceuticals Corporation $6,700.00 10/29/2025 Consulting Fee No dispute reported 06/30/2026 1200720193 CMS
Novartis Pharmaceuticals Corporation $83.33 10/23/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720189 CMS
Novartis Pharmaceuticals Corporation $69.37 10/04/2025 Food and Beverage No dispute reported 06/30/2026 1200720195 CMS
Novartis Pharmaceuticals Corporation $214.45 10/04/2025 Travel and Lodging No dispute reported 06/30/2026 1200720197 CMS
Novartis Pharmaceuticals Corporation $228.12 10/04/2025 Travel and Lodging No dispute reported 06/30/2026 1200720199 CMS
Novartis Pharmaceuticals Corporation $616.60 10/03/2025 Travel and Lodging No dispute reported 06/30/2026 1200720201 CMS
Novartis Pharmaceuticals Corporation $83.33 09/19/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720205 CMS
Stemline Therapeutics Inc. $6,240.00 09/01/2025 Consulting Fee No dispute reported 06/30/2026 1244091688 CMS
Stemline Therapeutics Inc. $214.21 09/01/2025 Travel and Lodging No dispute reported 06/30/2026 1244091690 CMS
Novartis Pharmaceuticals Corporation $83.33 08/21/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720185 CMS
Daiichi Sankyo Inc. $832.50 08/06/2025 Consulting Fee No dispute reported 06/30/2026 1197009353 CMS
Merck Sharp & Dohme LLC $150.00 08/06/2025 Travel and Lodging No dispute reported 06/30/2026 1237994844 CMS
Merck Sharp & Dohme LLC $7,680.00 08/06/2025 Consulting Fee No dispute reported 06/30/2026 1238000054 CMS
Stemline Therapeutics Inc. $218.30 07/26/2025 Travel and Lodging No dispute reported 06/30/2026 1244091684 CMS
Stemline Therapeutics Inc. $50.00 07/26/2025 Food and Beverage No dispute reported 06/30/2026 1244091692 CMS
Stemline Therapeutics Inc. $75.00 07/26/2025 Food and Beverage No dispute reported 06/30/2026 1244091694 CMS
Merck Sharp & Dohme LLC $30.00 07/25/2025 Food and Beverage No dispute reported 06/30/2026 1238000336 CMS
Merck Sharp & Dohme LLC $55.00 07/25/2025 Food and Beverage No dispute reported 06/30/2026 1238005010 CMS
Merck Sharp & Dohme LLC $65.00 07/25/2025 Food and Beverage No dispute reported 06/30/2026 1238008016 CMS
Merck Sharp & Dohme LLC $277.50 07/25/2025 Travel and Lodging No dispute reported 06/30/2026 1238033448 CMS
Merck Sharp & Dohme LLC $330.83 07/25/2025 Travel and Lodging No dispute reported 06/30/2026 1238038330 CMS
Novartis Pharmaceuticals Corporation $83.33 07/25/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720159 CMS
Stemline Therapeutics Inc. $673.67 07/25/2025 Travel and Lodging No dispute reported 06/30/2026 1244091686 CMS
Merck Sharp & Dohme LLC $301.39 07/24/2025 Travel and Lodging No dispute reported 06/30/2026 1237996324 CMS
Merck Sharp & Dohme LLC $26.32 07/24/2025 Food and Beverage No dispute reported 06/30/2026 1237998288 CMS
Merck Sharp & Dohme LLC $606.36 07/24/2025 Travel and Lodging No dispute reported 06/30/2026 1238006216 CMS
AstraZeneca Pharmaceuticals LP $1,340.00 07/16/2025 Consulting Fee No dispute reported 06/30/2026 1206403605 CMS
PFIZER INC. $837.40 06/29/2025 Travel and Lodging No dispute reported 06/30/2026 1230236715 CMS
PFIZER INC. $540.09 06/29/2025 Travel and Lodging No dispute reported 06/30/2026 1230236725 CMS
Novartis Pharmaceuticals Corporation $1,400.00 06/19/2025 Consulting Fee No dispute reported 06/30/2026 1200674984 CMS
Novartis Pharmaceuticals Corporation $99.70 06/12/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720157 CMS
AstraZeneca Pharmaceuticals LP $112.20 05/31/2025 Food and Beverage No dispute reported 06/30/2026 1206478773 CMS
Novartis Pharmaceuticals Corporation $99.70 05/15/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720153 CMS
Novartis Pharmaceuticals Corporation $99.70 04/24/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720155 CMS
Novartis Pharmaceuticals Corporation $99.70 03/26/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720151 CMS
Novartis Pharmaceuticals Corporation $1,400.00 03/21/2025 Consulting Fee No dispute reported 06/30/2026 1200674982 CMS
Novartis Pharmaceuticals Corporation $99.70 02/21/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720149 CMS
Novartis Pharmaceuticals Corporation $99.70 01/23/2025 Long term medical supply or device loan No dispute reported 06/30/2026 1200720147 CMS
AstraZeneca Pharmaceuticals LP $78.00 01/19/2025 Food and Beverage No dispute reported 06/30/2026 1206660587 CMS
Gilead Sciences, Inc. $42.60 01/17/2025 Food and Beverage No dispute reported 06/30/2026 1234415387 CMS
Eli Lilly and Company $1,600.00 01/10/2025 Consulting Fee No dispute reported 06/30/2026 1186638553 CMS
Eli Lilly and Company $2,800.00 01/10/2025 Consulting Fee No dispute reported 06/30/2026 1186650555 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
DAVID B PAGE, NPI 1922241140. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1922241140.
APA 7
IndustryPayments. (2026). DAVID B PAGE, NPI 1922241140 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1922241140
Bluebook
DAVID B PAGE, NPI 1922241140, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1922241140.

Source: Centers for Medicare & Medicaid Services, Open Payments.